Prevalence of UDP-glucuronosyltransferase polymorphisms (UGT1A6*2, 1A7*12, 1A8*3, 1A9*3, 2B7*2, and 2B15*2) in a Saudi population

被引:2
|
作者
Alkharfy, Khalid M. [1 ]
Jan, Basit L. [1 ]
Afzal, Sibtain [2 ,3 ]
Al-Jenoobi, Fahad I. [4 ]
Al-Mohizea, Abdullah M. [4 ]
Al-Muhsen, Saleh [2 ,3 ]
Halwani, Rabih [2 ,3 ]
Parvez, Mohammad K. [5 ]
Al-Dosari, Mohammed S. [5 ]
机构
[1] King Saud Univ, Dept Clin Pharm, Riyadh, Saudi Arabia
[2] King Saud Univ, Coll Med, Dept Pediat, Asthma Res Chair, Riyadh, Saudi Arabia
[3] King Saud Univ, Coll Med, Prince Naif Ctr Immunol Res, Riyadh, Saudi Arabia
[4] King Saud Univ, Dept Pharmaceut, Riyadh, Saudi Arabia
[5] King Saud Univ, Dept Pharmacognosy, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia
关键词
Glucuronidation; UDP-glucuronosyltransferase; UGT1A; UGT2B; Saudi gene polymorphism; CANCER-PATIENTS; HUMAN LIVER; MORPHINE GLUCURONIDATION; IRINOTECAN TOXICITY; ORAL MORPHINE; HUMAN COLON; 2B7; UGT2B7; IDENTIFICATION; METABOLISM; FLAVOPIRIDOL;
D O I
10.1016/j.jsps.2016.05.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Glucuronidation is an important phase II pathway responsible for many endogenous substances and drug metabolism. The present work evaluated allele frequencies of certain UDP-glucuronosyl-transferases (UGT 1A6*2, A7*12, A8*3, A9*3, 2B7*2, and 2B15*2) in Saudi Arabians that could provide essential ethnic information. Blood samples from 192 healthy unrelated Saudi males of various geographic regions were collected. Genomic DNA was isolated and genotyping of various UGTs was carried out using polymerase chain reaction (PCR) followed by direct sequencing. For UGT1A6*2 A/G genotype, the most common variant was the homozygous repeat (AA) and the most common allele was (A) with a frequency of 46.5% and 67.3%, respectively. Similarly, the most common variant for UGT1A7*12 T/C genotype was the heterozygous repeat (TC) with a frequency of 78.7% while the mutant allele (C) was present in 60.6% of the study population. Both UGT1A8*3 (G/A) and UGT1A9*3 (T/C) showed only a wild homozygous pattern in all screened subjects. For UGT2B7*2, the heterozygous repeat (TC) was found with a frequency of 57.3% and the alleles (A) showed a frequency of 50.8%. In contrast, for UGT2B15*2 (G253T), the heterozygous repeat (TG) presented 62.3% of the subjects where the most common allele (G) was with a frequency of 66.2%. In conclusion, our data indicate that Saudis harbor some important UGT mutations known to affect enzyme activity. Additional studies are therefore, warranted to assess the clinical implications of these gene polymorphisms in this ethnic group. (C) 2016 The Authors.
引用
收藏
页码:224 / 230
页数:7
相关论文
共 50 条
  • [41] Characterisation of interactions between UDP-glucuronosyltransferase 2B7 (UGT2B7) substrates using multisite kinetic modelling
    Uchaipichat, Verawan
    Mackenzie, Peter
    Houston, Brian
    Galetin, Aleksandra
    Miners, John
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 218 - 218
  • [42] Homodimerization of UDP-glucuronosyltransferase 2B7 (UGT2B7) and identification of a putative dimerization domain by protein homology modeling
    Lewis, Benjamin C.
    Mackenzie, Peter I.
    Miners, John O.
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (12) : 2016 - 2023
  • [43] Evaluation of 3′-azido-3′-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes:: Specificity and influence of the UGT2B7*2 polymorphism
    Court, MH
    Krishnaswamy, S
    Hao, Q
    Duan, SX
    Patten, CJ
    Von Moltke, LL
    Greenblatt, DJ
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (09) : 1125 - 1133
  • [44] Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7
    Innocenti, F
    Iyer, L
    Ramírez, J
    Green, MD
    Ratain, MJ
    DRUG METABOLISM AND DISPOSITION, 2001, 29 (05) : 686 - 692
  • [45] IN VITRO EVALUATION OF UDP-GLUCURONOSYLTRANSFERASE (UGT) 1A3 AND UGT2B4 INHIBITION
    Lapham, Kimberly
    Ferguson, Nicholas
    Novak, Jonathan
    Niosi, Mark
    Goosen, Theunis
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S52 - S53
  • [46] Contribution of UDP-glucuronosyltransferases 1A9 and 2B7 to the glucuronidation of indomethacin in the human liver
    Mano, Yuji
    Usui, Takashi
    Kamimura, Hidetaka
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (03) : 289 - 296
  • [47] Stereoselective Metabolism of Propranolol Glucuronidation by Human UDP-Glucuronosyltransferases 2B7 and 1A9
    Yu, Lushan
    Qian, Minrong
    Liu, Yao
    Yao, Tongwei
    Zeng, Su
    CHIRALITY, 2010, 22 (04) : 456 - 461
  • [48] Contribution of UDP-glucuronosyltransferases 1A9 and 2B7 to the glucuronidation of indomethacin in the human liver
    Yuji Mano
    Takashi Usui
    Hidetaka Kamimura
    European Journal of Clinical Pharmacology, 2007, 63 : 289 - 296
  • [49] Nonsteroidal anti-inflammatory drugs and phenols glucuronidation in Caco-2 cells - Identification of the UDP-glucuronosyltransferases UGT1A6, 1A3 and 2B7
    Sabolovic, N
    Magdalou, J
    Netter, P
    Abid, A
    LIFE SCIENCES, 2000, 67 (02) : 185 - 196
  • [50] Induction of human UDP glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-butylhydroquinone and 2,3,7,8-tetrachlorodibenzo-p-dioxin in Caco-2 cells
    Münzel, PA
    Schmohl, S
    Heel, H
    Kälberer, K
    Bock-Hennig, BS
    Bock, KW
    DRUG METABOLISM AND DISPOSITION, 1999, 27 (05) : 569 - 573